Fmoc or Boc: Which Chemistry Built Your Peptide, and What It Left Behind

Two chemistries have dominated peptide synthesis for fifty years. Which one was used determines the impurity profile of the material, and for some sequences it determines whether the synthesis succeeds at all.

The problem both strategies solve

A peptide is built one residue at a time on a solid support. At every step, exactly one amine must be free to react. The amine at the growing end must be exposed; every reactive side chain along the chain must stay masked.

So two classes of protecting group are needed: a **temporary** one on the growing end, removed at every cycle, and **permanent** ones on the side chains, removed once at the end. The design question is how to remove the temporary group many times without touching the permanent ones.

Boc: graduated acid lability

The older strategy solves it by degree. The temporary group, tert-butyloxycarbonyl, is removed by moderate acid — trifluoroacetic acid — at every cycle. The side-chain groups are chosen to survive that but to fall to a much stronger acid, historically anhydrous hydrogen fluoride, applied once at the end.

Both removals are acid; the strategy depends on the gap between them. That gap is real but finite, which means repeated cycles of moderate acid cause slow, cumulative loss of side-chain protection over a long synthesis.

The final cleavage is the practical obstacle. Hydrogen fluoride requires specialised apparatus, is acutely hazardous, and is not something most laboratories can run.

Fmoc: genuine orthogonality

The modern standard removes the temporary group with **base** — piperidine, typically 20% in dimethylformamide — and the permanent groups with **acid**, trifluoroacetic acid, at the end.

Base and acid are independent, so the two removals do not compete at all. There is no cumulative erosion across cycles, and the final cleavage uses an acid that any laboratory can handle. That combination is why Fmoc became dominant.

The side-chain set that pairs with it is the one whose masses appear on certificates: tert-butyl on hydroxyls and carboxyls, Boc on lysine, trityl on cysteine and the amides, Pbf on arginine. The mass each one adds if it survives cleavage is in protecting groups and the mass signatures of incomplete deprotection.

What each strategy leaves behind

The impurity profiles differ, and the difference is diagnostic.

Fmoc-specific: aspartimide formation. Repeated base treatment on an aspartate followed by glycine, and to a lesser degree by other small residues, cyclises the aspartate into a five-membered ring which then reopens as a mixture of aspartate and **isoaspartate**. The isoaspartate has the same mass as the parent and a different backbone, so it is invisible to mass spectrometry and detectable only chromatographically. The same chemistry appears as a storage degradation route, described in deamidation and the 0.98 dalton shift.

Also Fmoc-specific: incomplete removal of the temporary group leaves a species 222 daltons above the target, and the removed group’s by-product must be scavenged by the piperidine or it re-adds.

Boc-specific: cumulative acid exposure. Sensitive residues — tryptophan in particular — degrade under repeated acid treatment, and the extent scales with the number of cycles, so a long Boc synthesis carries more of it than a short one.

Where Boc is still the right choice

Two situations, both about aggregation.

Long or hydrophobic sequences can fold and associate on the resin while they are being built. An aggregated chain buries its reactive end, couplings fail, and deletion sequences multiply. **Repeated trifluoroacetic acid treatment disrupts that secondary structure**, so the Boc cycle actively works against aggregation in a way the Fmoc cycle does not.

This is why very long syntheses, and sequences known to be difficult, are sometimes run by Boc chemistry despite the cleavage problem. It is also why a laboratory quoting a long sequence may quote differently depending on which route it intends.

What this means when reading a certificate

The strategy is rarely stated, and it usually does not need to be. Where it helps is in interpreting an unexplained peak:

• A late-eluting species at exactly +56, +100, +242 or +253 daltons is a retained side-chain group — Fmoc-strategy chemistry.
• A species at +222 is a retained temporary group, meaning a cycle failed mid-synthesis.
• A chromatographic shoulder with **no** mass difference, on a sequence containing aspartate followed by glycine, is the aspartimide route and is characteristic.

Identifying an impurity by class rather than as an unnamed peak is what makes it possible to say whether it will grow on storage. The general impurity families are covered in deletion, truncation and oxidation impurities.

Neither strategy is a quality claim

A peptide made by either route, purified to the same specification and measured by the same method, is the same material. The strategy determines which impurities were likely, not how pure the final product is — and the purification step, not the synthesis strategy, is what sets the number on the certificate.